Roxanne Lagano - Zoetis President

ZTS -- USA Stock  

Fiscal Quarter End: December 31, 2019  

  President
Ms. Roxanne Lagano is Executive Vice President, Chief Human Resources Officer and Communications of Zoetis Inc. Ms. Lagano has served as our Executive Vice President and Chief Human Resources Officer since November 2012 and was given responsibility for corporate communications in 2015. Prior to joining Zoetis, Ms. Lagano was Senior Vice President, Global Compensation, Benefits and Wellness for Pfizer. Ms. Lagano joined Pfizer in 1997 and held various positions, including Senior Director, Business Transactions, Pfizer Worldwide Human Resources.
Age: 53  President Since 2015      
973 822-7000  www.zoetis.com
Lagano joined Pfizer in 1997 and held various positions, including Senior Vice President, Pfizer Global Compensation, Benefits and Wellness; and Senior Director, Business Transactions, Pfizer Worldwide Human Resources.

Roxanne Lagano Latest Insider Activity

Management Efficiency

The company has Return on Asset of 11.71 % which means that on every $100 spent on asset it made $11.71 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 60.93 % implying that it generated $60.93 on every 100 dollars invested.
The company has 6.66 B in debt with debt to equity (D/E) ratio of 248.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.3 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Umang VohraDr Reddys Laboratories Ltd
2013
Amit BiswasDr Reddys Laboratories Ltd
2016
Paul WeningerPerrigo Company Plc
2015
J RamachandranDr Reddys Laboratories Ltd
2016
Ian SmithVertex Pharmaceuticals Incorpor
2017
Jay MarkowitzRegeneron Pharmaceuticals
2017
Raghav ChariDr Reddys Laboratories Ltd
2013
Alok SonigDr Reddys Laboratories Ltd
2015
Scott JamisonPerrigo Company Plc
2011
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Charles WagnerVertex Pharmaceuticals Incorpor
2019
George YancopoulosRegeneron Pharmaceuticals
2016
Kimberly WhiteVertex Pharmaceuticals Incorpor
2018
Cartikeya ReddyDr Reddys Laboratories Ltd
2016
John GrayVertex Pharmaceuticals Incorpor
2019
James MichaudPerrigo Company Plc
2016
Marc CouckePerrigo Company Plc
N/A
John WesolowskiPerrigo Company Plc
2016
Louis YuPerrigo Company Plc
2013
Michael AbermanRegeneron Pharmaceuticals
2015
Joseph LaRosaRegeneron Pharmaceuticals
2019

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drugs - Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Also Currentnly Active

Purchased over 300 shares of
few hours ago
Traded for 52.7
Purchased over 90 shares of
few hours ago
Traded for 262.64
Purchased over 100 shares of
few hours ago
Traded for 87.63
See also Your Current Watchlist. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Search macroaxis.com